Nigral degeneration in Parkinson's disease in relation to clinical features
Identifieur interne : 002692 ( Main/Exploration ); précédent : 002691; suivant : 002693Nigral degeneration in Parkinson's disease in relation to clinical features
Auteurs : J. O. Rinne [Finlande]Source :
- Acta Neurologica Scandinavica [ 0001-6314 ] ; 1991-10.
English descriptors
Abstract
Neuronal loss in the substantia nigra (SN) in Parkinson's disease (PD) shows a topographical organisation where the lateral part of the SN is more affected. This is ‐ due to projection of the lateral SN mainly to the putamen ‐ reflected in more complete loss of dopamine content in the putamen than in the caudate nucleus. Of the parkinsonian symptoms rigidity and hypokinesia are associated with neuronal loss in the lateral substantia nigra and the resulting dopamine loss in the putamen. Neuronal mechanisms other than degeneration of the nigrostriatal system seem to be involved in the pathophysiology of tremor. Cognitive impairment and dementia in PD is related to dysfunction of the cortical cholinergic system, especially in the frontal cortex. The brain dopaminergic system, however, contributes as a subcortical component to cognitive impairment in PD. Clinical studies have shown that selegiline may slow down the progression of PD. We studied postmortem samples of patients treated with selegiline and levodopa and those with levodopa alone. The number of medial nigral neurons was significantly higher in the selegiline group. Treatment with selegiline might retard the death of nigral neurons, but further studies are needed to confirm the preliminary findings.
Url:
DOI: 10.1111/j.1600-0404.1991.tb05026.x
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Nigral degeneration in Parkinson's disease in relation to clinical features</title><author><name sortKey="Rinne, J O" sort="Rinne, J O" uniqKey="Rinne J" first="J. O." last="Rinne">J. O. Rinne</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:C76B1114D1E86E00446608A706B84017C5BB6FC0</idno><date when="1991" year="1991">1991</date><idno type="doi">10.1111/j.1600-0404.1991.tb05026.x</idno><idno type="url">https://api.istex.fr/document/C76B1114D1E86E00446608A706B84017C5BB6FC0/fulltext/pdf</idno><idno type="wicri:Area/Main/Corpus">001E35</idno><idno type="wicri:Area/Main/Curation">001B49</idno><idno type="wicri:Area/Main/Exploration">002692</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Nigral degeneration in Parkinson's disease in relation to clinical features</title><author><name sortKey="Rinne, J O" sort="Rinne, J O" uniqKey="Rinne J" first="J. O." last="Rinne">J. O. Rinne</name><affiliation wicri:level="4"><country xml:lang="fr">Finlande</country><wicri:regionArea>Department of Neurology, University of Turku, Turku</wicri:regionArea><placeName><settlement type="city">Turku</settlement><region type="région" nuts="2">Finlande occidentale</region></placeName><orgName type="university">Université de Turku</orgName></affiliation></author></analytic><monogr></monogr><series><title level="j">Acta Neurologica Scandinavica</title><idno type="ISSN">0001-6314</idno><idno type="eISSN">1600-0404</idno><imprint><publisher>Blackwell Publishing Ltd</publisher><pubPlace>Oxford, UK</pubPlace><date type="published" when="1991-10">1991-10</date><biblScope unit="volume">84</biblScope><biblScope unit="issue">S136</biblScope><biblScope unit="page" from="87">87</biblScope><biblScope unit="page" to="90">90</biblScope></imprint><idno type="ISSN">0001-6314</idno></series><idno type="istex">C76B1114D1E86E00446608A706B84017C5BB6FC0</idno><idno type="DOI">10.1111/j.1600-0404.1991.tb05026.x</idno><idno type="ArticleID">ANE87</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0001-6314</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Lewy bodies</term><term>Parkinson's disease</term><term>deprenyl</term><term>neuron counts</term><term>selegiline</term><term>substantia nigra</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Neuronal loss in the substantia nigra (SN) in Parkinson's disease (PD) shows a topographical organisation where the lateral part of the SN is more affected. This is ‐ due to projection of the lateral SN mainly to the putamen ‐ reflected in more complete loss of dopamine content in the putamen than in the caudate nucleus. Of the parkinsonian symptoms rigidity and hypokinesia are associated with neuronal loss in the lateral substantia nigra and the resulting dopamine loss in the putamen. Neuronal mechanisms other than degeneration of the nigrostriatal system seem to be involved in the pathophysiology of tremor. Cognitive impairment and dementia in PD is related to dysfunction of the cortical cholinergic system, especially in the frontal cortex. The brain dopaminergic system, however, contributes as a subcortical component to cognitive impairment in PD. Clinical studies have shown that selegiline may slow down the progression of PD. We studied postmortem samples of patients treated with selegiline and levodopa and those with levodopa alone. The number of medial nigral neurons was significantly higher in the selegiline group. Treatment with selegiline might retard the death of nigral neurons, but further studies are needed to confirm the preliminary findings.</div></front></TEI><affiliations><list><country><li>Finlande</li></country><region><li>Finlande occidentale</li></region><settlement><li>Turku</li></settlement><orgName><li>Université de Turku</li></orgName></list><tree><country name="Finlande"><region name="Finlande occidentale"><name sortKey="Rinne, J O" sort="Rinne, J O" uniqKey="Rinne J" first="J. O." last="Rinne">J. O. Rinne</name></region></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002692 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 002692 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:C76B1114D1E86E00446608A706B84017C5BB6FC0
|texte= Nigral degeneration in Parkinson's disease in relation to clinical features
}}
| This area was generated with Dilib version V0.6.23. |  |